Chattem Appoints Riker VP R&D
January 14, 2002
1 Min Read
Chattem Appoints Riker VP R&D
CHATTANOOGA, Tenn.--Chattem Inc. (www.chattem.com)announced that Donald Riker, Ph.D., has been appointed vice president ofresearch & development and chief scientific officer. Riker has nearly 20years of leadership experience in clinical-regulatory affairs, licensing andinnovative OTC product development both at Richardson-Vicks and Procter &Gamble Healthcare. He is a member of several associations, including theAmerican Academy of Allergy, Asthma & Immunology and the American Societyfor Clinical Pharmacology & Therapeutics.
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
You May Also Like